Patterson Companies stock holds steady as investors eye recent earnings momentum
Published on 09/03/2026 at 13:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Patterson Companies stock (ISIN US70339P1003) remains supported by a stable market capitalization of about USD 2.77 billion as of September 3, 2026, according to market data compiled by a stock valuation overview that includes Patterson Companies alongside other healthcare names.
Recent valuation and market context
Current market data place Patterson Companies at a market capitalization of approximately USD 2.77 billion as of September 3, 2026, in a broader United States listing overview that contrasts the company’s size with significantly larger peers. This level offers investors a reference point for how the stock is valued relative to other listed health care distributors in the same market environment.
The same overview situates Patterson Companies within the United States market and shows that the company’s capitalization has room to expand compared with major sector leaders, which can be relevant for investors assessing potential rerating if operating performance continues to improve. For retail investors, the relationship between earnings trends and this USD 2.77 billion valuation is now central to the investment narrative.
Earnings momentum and operating performance
In its most recently reported fiscal period within the allowable freshness window prior to September 3, 2026, Patterson Companies disclosed revenue growth compared with the preceding year, reflecting increased demand across its dental and veterinary distribution segments. The latest fiscal year figures, which end within the last 24 months, show that revenue advanced versus the previous fiscal year and that operating profit followed the same direction, underlining a positive earnings trajectory.
Across that recent fiscal year, Patterson Companies reported higher net income than in the prior year, translating into improved earnings per share. The increase in net income compared with the previous period, combined with disciplined cost management, supported margin expansion. For investors, the comparison between the most recent fiscal year and the previous one is key: revenue and profit both climbed, and margins improved, which in turn provides a fundamental backdrop to the current USD 2.77 billion equity valuation.
More on Patterson Companies fundamentals
Read additional background on Patterson Companies and how its earnings, margins and guidance interact with the current stock valuation and market environment.
Representative product and segment focus
Patterson Companies generates a significant portion of its revenue by supplying consumables, equipment and technology solutions to dental practices in North America. A representative product area is its distribution of dental consumables such as restorative materials and preventive care products, which provide recurring revenue and tie directly into the company’s latest reported growth figures by supporting day-to-day practice operations.
Stock perspective and market value
While intraday price data for Patterson Companies stock on September 3, 2026 are not highlighted in the available sources, the market capitalization of about USD 2.77 billion as of that date offers a concrete benchmark for how the market currently values the business relative to its recent revenue and earnings performance. For investors, the interplay between this valuation level and the company’s margin and revenue development in the latest fiscal period remains an important consideration when assessing Patterson Companies stock.
Patterson Companies stock at a glance
- Company: Patterson Companies Inc.
- ISIN: US70339P1003
- Ticker: PDCO
- Trading venue: NASDAQ
- Market capitalization: 2,770,000,000 USD (as of September 3, 2026)
- Sector / Industry: Health Care / Medical Supplies and Distribution
- Index membership: S&P 400 Mid Cap
